Search results for " Mental disorder"

showing 10 items of 106 documents

Bipolar I and Bipolar II Disorder: Cognition and Emotion Processing

2006

Background. Cognitive impairment may be part of the endophenotype of bipolar disorder (BP), but little is known about patterns and severity of impairment in BP subgroups and their relation to depression. The same applies to deficits in emotion processing known to be present in BP.Method. To explore the relationship between depression and impairment in cognition and emotion processing and the differences between BP subgroups, we assessed 36 (25 BP I and 11 BP II) patients using a cognitive battery and a facial emotion recognition task.Results. BP patients were impaired compared to published norms on memory, naming and executive measures (Binomial Single Proportion tests, p<0·05). Cognitiv…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentNeuropsychological TestsSeverity of Illness IndexBipolar II disorderElectroconvulsive therapymedicineHumansEffects of sleep deprivation on cognitive performanceBipolar disorderPsychiatryApplied PsychologySettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitive disorderCognitionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthAffectEndophenotypeFemaleAdult Affect* Bipolar Disorder/diagnosis* Bipolar Disorder/epidemiology* Cognition Disorders/diagnosis Cognition Disorders/epidemiology Diagnostic and Statistical Manual of Mental Disorders Female Humans Male Neuropsychological Tests Severity of Illness Indexmedicine.symptomPsychologyCognition DisordersManiaClinical psychology
researchProduct

A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness.

2003

Abstract Objective: The purpose of this prospective study was to evaluate the effects of cognitive-behavioral treatment (CBT) on mental health status and healthcare utilization in patients with somatoform disorders (SFD) of a specialized tertiary care center. Methods: According to DSM-IV interviews, 54 patients had somatization disorder (SD), 51 abridged somatization syndrome (SSI-8) and 67 other defined SFD. A clinical non-SFD comparison group consisted of 123 patients. Treatment effects were controlled against the waiting list. Cost calculations for the 2-year periods before and after treatment were based on medical and billing records from health insurance companies. Results: The SFD pat…

AdultMalemedicine.medical_specialtyCost effectivenessCost-Benefit AnalysisSampling StudiesSurveys and QuestionnairesmedicineHumansSomatization disorderProspective StudiesPsychiatrySomatoform DisordersAgedInpatient careCognitive Behavioral Therapybusiness.industryDepressionPublic healthCost-effectiveness analysisHealth ServicesMiddle Agedmedicine.diseaseMental healthDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologySocioeconomic FactorsPhysical therapyFemalebusinessPsychosocialSomatizationFollow-Up StudiesJournal of psychosomatic research
researchProduct

High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment

2017

BackgroundCognitive reserve (CR) reflects the capacity of the brain to endure neuropathology, minimize clinical manifestations and successfully complete cognitive tasks. The present study aims to determine whether high CR may constitute a moderator of cognitive functioning in bipolar disorder (BD).MethodsOne hundred and two patients with BD and 32 healthy controls were enrolled. All patients met DSM-IV criteria for I or II BD and were euthymic (YMRS ≤ 6 and HDRS ≤ 8) during a 6-month period. All participants were tested with a comprehensive neuropsychological battery, and a Cerebral Reserve Score (CRS) was estimated. Subjects with a CRS below the group median were classified as having low C…

AdultMalemedicine.medical_specialtyElementary cognitive taskBipolar DisorderBipolar disorderCognitive reserveNeuropsychological TestsAudiologyYoung Adult03 medical and health sciences0302 clinical medicineCognitive ReservemedicineHumansVerbal fluency testCognitive skillBipolar disorderPsychiatryNeurocognitionCognitive reserveCalifornia Verbal Learning TestBipolar disorder Cognitive heterogeneity Cognitive reserve NeurocognitionMiddle Agedmedicine.diseaseCyclothymic Disorder030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesCognitive remediation therapyFemaleCuesVerbal memoryCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryCognitive heterogeneityJournal of Affective Disorders
researchProduct

Screening for generalized anxiety disorder in Spanish primary care centers with the GAD-7.

2017

The aim of the study was to determine the criterion validity of a computerized version of the General Anxiety Disorder-7 (GAD-7) questionnaire to detect general anxiety disorder in Spanish primary care centers. A total of 178 patients completed the GAD-7 and were administered the Composite International Diagnostic Interview (CIDI) for DSM-IV Axis I Disorders, which was used as a reference standard. Sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios were calculated. A cut-off of 10 yielded a sensitivity of .87, a specificity of .78, a positive predictive value of .93, a negative predictive value of .64, a positive likelihood ratio o…

AdultMalemedicine.medical_specialtyGeneralized anxiety disorderAdolescentPrimary careLikelihood ratios in diagnostic testingSensitivity and SpecificityComputerized instruments03 medical and health sciencesYoung Adult0302 clinical medicineGeneralized anxiety disorderPredictive Value of TestsReference ValuesPositive predicative valueSurveys and QuestionnairesmedicineCriterion validityHumansMass Screening030212 general & internal medicinePsychiatryBiological PsychiatryGAD-7AgedPsychological TestsPrimary Health CareReproducibility of ResultsCriterion validityMiddle Agedmedicine.diseaseCIDIPrimary careAnxiety DisordersHealth Surveys030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthSpainScreeningAnxietyFemalemedicine.symptomPsychologyAnxiety disorderClinical psychology
researchProduct

The Calgary Depression Rating Scale for schizophrenia in a healthy control group: Psychometric properties and reference values

2005

Abstract Background Assessment of depression in schizophrenia is of great importance as depressive signs and symptoms and suicidality are highly prevalent in patients with schizophrenic disorders. The Calgary Depression Rating Scale (CDSS) is the standard assessment instrument for that purpose due to its proven reliability and validity. However, so far no reference values derived from an adequate healthy sample have been published. Methods The present study analyzed CDSS item scores and summary scores in 154 healthy subjects (49% female, mean age 32.8 ± 11.7 years) selected from studies as controls for schizophrenic patients. Results The total CDSS score was 2.6 ± 2.7 (range 0–12), about 1/…

AdultMalemedicine.medical_specialtyPsychometricsPsychometricsCross-sectional studyStatistics as TopicComorbidityTest validityCronbach's alphaInternational Classification of DiseasesReference ValuesRating scalemedicineHumansPsychiatrySuicidal ideationPsychiatric Status Rating ScalesDepressive DisorderReproducibility of ResultsMiddle Agedmedicine.diseaseComorbidityDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesSchizophreniaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyClinical psychologyJournal of Affective Disorders
researchProduct

Utility of the PHQ-9 to identify major depressive disorder in adult patients in Spanish primary care centres.

2017

Abstract Background The prevalence of major depressive disorder (MDD) in Spanish primary care (PC) centres is high. However, MDD is frequently underdiagnosed and consequently only some patients receive the appropriate treatment. The present study aims to determine the utility of the Patient Health Questionnaire-9 (PHQ-9) to identify MDD in a subset of PC patients participating in the large PsicAP study. Methods A total of 178 patients completed the full PHQ test, including the depression module (PHQ-9). Also, a Spanish version of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) was implemented by clinical psychologists that were blinded to the PHQ-9 results. We evaluat…

AdultMalemedicine.medical_specialtyPsychometricsPsychometricslcsh:RC435-571Primary careMajor depressive disorderPatient Health Questionnairebehavioral disciplines and activitiesSensitivity and Specificity03 medical and health sciences0302 clinical medicinePredictive Value of Testslcsh:Psychiatrymental disordersMedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive Disorder MajorPrimary Health Carebusiness.industryPatient health questionnaire-9medicine.diseasePrimary carePatient Health QuestionnaireDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPsychometric propertiesMoodPsychologieSpainPredictive value of testsMajor depressive disorderAnxietyFemalemedicine.symptombusiness030217 neurology & neurosurgeryClinical psychologyResearch ArticleBMC psychiatry
researchProduct

Differentiating moderate and severe depression using the Montgomery–Åsberg depression rating scale (MADRS)

2003

MADRS cut-off scores for moderate and severe depression were estimated in relation to the Hamilton Depression Rating Scale (HAMD(17)) and the Clinical Global Impressions Scale (CGI).HAMD(17), MADRS, and CGI ratings from patients with major depression (DSM-IV) were analyzed (N=85). Receiver operating characteristics (ROC) curves were applied.Mean age was 51.4+/-14.5 years, 69% were female. Mean MADRS scores were 23.4+/-13.2, HAMD(17), MADRS, and CGI scores were highly correlated (r0.85; P0.0001). Best separation between moderate and severe depression according to CGI criteria was achieved with a MADRS score of 31 (sensitivity 93.5%, specificity 83.3%).Studies to validate severity gradations …

AdultMalemedicine.medical_specialtyPsychometricsTest validitySeverity of Illness IndexDiagnosis DifferentialReference ValuesRating scalemental disordersSeverity of illnessmedicineHumansPsychiatryDepression (differential diagnoses)AgedDepressive DisorderReceiver operating characteristicMiddle AgedhumanitiesDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyMontgomery–Åsberg Depression Rating ScaleFemaleMental Status SchedulePsychologyPsychopathologyJournal of Affective Disorders
researchProduct

High Prevalence of Mental Disorders and Emotional Distress in Patients with Chronic Spontaneous Urticaria

2011

Quality of life, which is impaired in patients with chronic spontaneous urticaria (CSU), is influenced by comorbid mental disorders. The aim of this study was to assess the prevalence and spectrum of mental disorders and to determine levels of emotional distress in patients with CSU. One hundred patients with CSU were investigated for mental disorders (by specialized diagnostic interviews and psychometric instruments), levels of emotional distress (by the Global Severity Index of the Symptom Check List; SCL-90R GSI) and underlying causes of their urticaria (by dermatological assessment). Forty-eight percent of patients with CSU were diagnosed with one or more psychosomatic disorders; most c…

AdultMalemedicine.medical_specialtyPsychometricsUrticariaPsychometricsEmotionsComorbidityDermatologyInterviews as TopicQuality of life (healthcare)Prevalence of mental disordersPredictive Value of TestsRisk FactorsGermanyPrevalencemedicineHumansPsychiatryDepression (differential diagnoses)Phobiasbusiness.industryMental DisordersGeneral Medicinemedicine.diseaseComorbidityChecklistClinical trialChronic DiseaseQuality of LifeAnxietyFemalemedicine.symptombusinessStress PsychologicalActa Dermato Venereologica
researchProduct

Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response

2008

The aim of the present study was to examine the relevance of depressive symptoms during an acute schizophrenic episode for the prediction of treatment response. Two hundred inpatients who fulfilled DSM-IV criteria for schizophrenia or schizophreniform disorders were assessed at hospital admission and after 6 weeks of inpatient treatment using the Positive and Negative Syndrome Scale (PANSS) and the Hamilton Rating Scale for Depression (HAM-D). Depressive symptoms showed positive correlations with both positive and negative symptoms at admission and after 6 weeks, and decreased during 6 weeks of treatment. Pronounced depressive symptoms (HAM-D score> or =16) were found in 28% of the sample a…

AdultMalemedicine.medical_specialtyPsychosis610 Medicine & healthComorbidity10056 Clinic for Clinical and Social Psychiatry Zurich West (former)law.invention2738 Psychiatry and Mental Health03 medical and health sciencesPatient Admission0302 clinical medicineRandomized controlled triallawInternal medicinemental disordersmedicineHumansSchizophreniform disorderPsychiatryBiological PsychiatryDepression (differential diagnoses)ProbabilityPsychiatric Status Rating ScalesDepressive DisorderDepressive Disorder MajorPsychotropic DrugsPositive and Negative Syndrome ScaleHamilton Rating Scale for Depressionmedicine.diseaseComorbidity030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersHospitalizationPsychiatry and Mental healthTreatment OutcomePsychotic DisordersSchizophreniaAcute DiseaseSchizophreniaFemaleSchizophrenic PsychologyPsychology2803 Biological Psychiatry030217 neurology & neurosurgeryAntipsychotic AgentsFollow-Up Studies
researchProduct

A possible association between the CCK-AR gene and persistent auditory hallucinations in schizophrenia.

2004

AbstractRecent studies have suggested that DNA variations in the CCK-AR gene might predispose individuals to schizophrenia and particularly to auditory hallucinations (AH). The aim of this study is to assess the association between AH, using a specific scale for AH in schizophrenia (PSYRATS), and the CCK-AR polymorphism at 779 in a Spanish sample. A total of 105 DSM-IV schizophrenic patients with AH and 93 unrelated controls were studied. Twenty-two patients were considered as persistent auditory hallucinators, which showed similar clinical and demographic characteristic than patients with episodic AH, but with the exception of the PSYRATS values. The persistent AH group showed an excess of…

AdultMalemedicine.medical_specialtyPsychosisPeriodicityGenotypeHallucinationsSeverity of Illness IndexGenetic determinismLinkage Disequilibrium03 medical and health sciences0302 clinical medicineGene FrequencyInternal medicineSurveys and QuestionnairesSeverity of illnessmedicineHumansAlleleSex DistributionPsychiatryAllele frequencyGenetic associationDNA PrimersDemographyAuditory hallucinationPolymorphism Geneticmedicine.diseaseIntrons030227 psychiatryReceptor Cholecystokinin ADiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthEndocrinologySchizophreniaSchizophreniaFemalemedicine.symptomPsychology030217 neurology & neurosurgeryEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct